Veröffentlichungen
Filter: Anfangsbuchstabe Des Nachnamens is B [Alle Filter zurücksetzen]
5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo." Eur Neuropsychopharmacol. 2003;13(3):153-64.
"5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placebo." Eur Neuropsychopharmacol. 2003;13(3):153-64.
"Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects." Psychopharmacology (Berl.). 2001;155(3):234-41.
"Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects." Psychopharmacology (Berl.). 2001;155(3):234-41.
"Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects." Psychopharmacology (Berl.). 2001;155(3):234-41.
"Reliability of gas exchange measurements from two different spiroergometry systems." Int J Sports Med. 2001;22(8):593-7.
"Therapeutic impact of exercise on psychiatric diseases: guidelines for exercise testing and prescription." Sports Med. 2000;30(4):269-79.
"The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial." Pharmacopsychiatry. 2000;33(5):174-81.
"The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial." Pharmacopsychiatry. 2000;33(5):174-81.
"The use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial." Pharmacopsychiatry. 2000;33(5):174-81.
"Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners." Neuropsychopharmacology. 1999;20(2):150-61.
"Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners." Neuropsychopharmacology. 1999;20(2):150-61.
"Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners." Neuropsychopharmacology. 1999;20(2):150-61.
"The Role of Aerobic Exercise in the Treatment of Panic Disorder." Directions in Psychiatry . 1999;19:163-175.
"The Role of Aerobic Exercise in the Treatment of Panic Disorder." Directions in Psychiatry . 1999;19:163-175.
"Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder." Am J Psychiatry. 1998;155(5):603-9.
"Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder." Am J Psychiatry. 1998;155(5):603-9.
"Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder." Am J Psychiatry. 1998;155(5):603-9.
"Endurance training in panic patients: spiroergometric and clinical effects." Int J Sports Med. 1998;19(7):496-502.
"Endurance training in panic patients: spiroergometric and clinical effects." Int J Sports Med. 1998;19(7):496-502.
"Exercise avoidance and impaired endurance capacity in patients with panic disorder." Neuropsychobiology. 1997;36(4):182-7.
"Exercise avoidance and impaired endurance capacity in patients with panic disorder." Neuropsychobiology. 1997;36(4):182-7.
"Exercise avoidance and impaired endurance capacity in patients with panic disorder." Neuropsychobiology. 1997;36(4):182-7.
"Zum Stellenwert von Sport in der Behandlung psychischer Erkrankungen." Psychother Psychosom med Psychol . 1997;47:379-393.
"Zum Stellenwert von Sport in der Behandlung psychischer Erkrankungen." Psychother Psychosom med Psychol . 1997;47:379-393.
" "
- erster
- vorheriges
- 1
- 2
- 3